immunomeinc
The Principal Scientist, Chemical Development will lead small molecule process development and manufacturing efforts for Immunome's targeted cancer therapy pipeline, focusing on linker-payloads for antibody drug conjugates. The role combines technical leadership, hands‑on bench work, and collaboration with internal teams and external partners to advance robust, scalable synthetic routes and support regulatory submissions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for immunomeinc.
37% above the average for this role
Senior Scientist (Synthetic Chemistry)
AstraZeneca
Senior Associate Scientist, R&D Chemistry
Regeneron Pharmaceuticals
Scientist, R&D Chemistry, Peptidomimetic Synthesis
Regeneron Pharmaceuticals
Advisor ADC Drug-Linker Synthetic Process Development
Eli Lilly and Company
Scientist – Protein Engineering – Organic Chemist: ADC Research & Development
Amgen
Organic and Conjugation Chemist
Amgen